Mild Parkinsonian signs: An overview of an emerging concept

被引:127
作者
Louis, Elan D.
Bennett, David A.
机构
[1] Columbia Univ, Coll Phys & Surg, GH Sergievsky Ctr, Inst Neurol, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
[3] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
parkinsonism; aging; elderly; epidemiology; DISEASE-RATING-SCALE; TO-DOOR SURVEY; EXTRAPYRAMIDAL SIGNS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; COMMUNITY POPULATION; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; CIGARETTE-SMOKING;
D O I
10.1002/mds.21433
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mild Parkinsonian signs (MPS) include gait and balance changes, rigidity, bradykinesia, and tremor. MPS can occur commonly during the clinical examination of older people who do not have known neurological disease, with prevalence estimates for MPS as a whole ranging from 15% to 95%. MPS are generally progressive and they are coupled with functional difficulties, impaired gait and balance, and increased risks of mild cognitive impairment, dementia, and mortality. The mechanistic basis for these signs is unclear, but is likely to be multifactorial, with possible factors including an age-associated decline in dopaminergic nigrostriatal activity, the early development of neurodegenerative (Lewy body or Alzheimer's type) pathologies in the basal ganglia, or the accumulation of vascular pathology in the brain. It would be valuable to identify those individuals with MPS who are at increased risk for the development of future Alzheimer's disease, full-blown Parkinson's disease, or strokes, and to develop therapeutic strategies to intervene to lessen the likelihood of MPS-related morbidity and mortality. (C) 2007 Movement Disorder Society.
引用
收藏
页码:1681 / 1688
页数:8
相关论文
共 75 条
[11]   PREVALENCE OF PARKINSONS-DISEASE IN THE PARSI COMMUNITY OF BOMBAY, INDIA [J].
BHARUCHA, NE ;
BHARUCHA, EP ;
BHARUCHA, AE ;
BHISE, AV ;
SCHOENBERG, BS .
ARCHIVES OF NEUROLOGY, 1988, 45 (12) :1321-1323
[12]   Parkinsonian signs in subjects with mild cognitive impairment [J].
Boyle, PA ;
Wilson, RS ;
Aggarwal, NT ;
Arvanitakis, Z ;
Kelly, J ;
Bienias, JL ;
Bennett, DA .
NEUROLOGY, 2005, 65 (12) :1901-1906
[13]  
Breteler Monique M. B., 1996, Neurology, V46, pA332
[14]   The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs [J].
Burns, JM ;
Galvin, JE ;
Roe, CM ;
Morris, JC ;
McKeel, DW .
NEUROLOGY, 2005, 64 (08) :1397-1403
[15]   CRITERIA FOR DIAGNOSING PARKINSONS-DISEASE [J].
CALNE, DB ;
SNOW, BJ ;
LEE, C .
ANNALS OF NEUROLOGY, 1992, 32 :S125-S127
[16]   VASCULAR PSEUDOPARKINSONISM [J].
CHANG, CM ;
YU, YL ;
NG, HK ;
LEUNG, SY ;
FONG, KY .
ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (06) :588-592
[17]   Prevalence, incidence, and mortality of PD - A door-to-door survey in Ilan County, Taiwan [J].
Chen, RC ;
Chang, SF ;
Su, CL ;
Chen, THH ;
Yen, MF ;
Wu, HM ;
Chen, ZY ;
Liou, HH .
NEUROLOGY, 2001, 57 (09) :1679-1686
[18]  
Cubo E, 2000, MOVEMENT DISORD, V15, P276, DOI 10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO
[19]  
2-Q
[20]   Prevalence of Parkinson's disease in the elderly: The Rotterdam study [J].
deRijk, MC ;
Breteler, MMB ;
Graveland, GA ;
Ott, A ;
Grobbee, DE ;
vanderMeche, FGA ;
Hofman, A .
NEUROLOGY, 1995, 45 (12) :2143-2146